BR9715082A - Sistemas transdérmicos contendo dois princìpios ativos em compartimentos separados, seu processo de preparo e sua aplicação como medicamento - Google Patents

Sistemas transdérmicos contendo dois princìpios ativos em compartimentos separados, seu processo de preparo e sua aplicação como medicamento

Info

Publication number
BR9715082A
BR9715082A BR9715082-7A BR9715082A BR9715082A BR 9715082 A BR9715082 A BR 9715082A BR 9715082 A BR9715082 A BR 9715082A BR 9715082 A BR9715082 A BR 9715082A
Authority
BR
Brazil
Prior art keywords
application
preparation process
active ingredients
separate compartments
medicine
Prior art date
Application number
BR9715082-7A
Other languages
English (en)
Inventor
Jean-Luc Dubois
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of BR9715082A publication Critical patent/BR9715082A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)

Abstract

"SISTEMAS TRANSDéRMICOS CONTENDO DOIS PRINCìPIOS ATIVOS EM COMPARTIMENTOS SEPARADOS, SEU PROCESSO DE PREPARO E SUA APLICAçãO COMO MEDICAMENTO". A invenção tem por objeto um dispositivo destinado à administração transdérmica de dois princípios ativos (1) e (11) constituídos de dois compartimentos (A) e (B), o compartimento (A) contendo uma matriz carregada com (1) e o compartimento (B) contendo uma matriz carregada com (11), cada uma dessas matrizes sendo recoberta, respectivamente, com uma película de proteção, de natureza idêntica ou não, (a) e (a'), caracterizado pelo fato de (A) ser separado de (B) por um espaço vazio de 1 a 10 mm e caracterizado pelo fato de (A) e (B) serem suportados pela mesma película protetora destacável (b), seu processo de preparo e sua aplicação como medicamento.
BR9715082-7A 1996-06-11 1997-06-10 Sistemas transdérmicos contendo dois princìpios ativos em compartimentos separados, seu processo de preparo e sua aplicação como medicamento BR9715082A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607209A FR2749514B1 (fr) 1996-06-11 1996-06-11 Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament
PCT/FR1997/001024 WO1997047305A1 (fr) 1996-06-11 1997-06-10 Systemes transdermiques renfermant deux principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament

Publications (1)

Publication Number Publication Date
BR9715082A true BR9715082A (pt) 2003-07-15

Family

ID=9492920

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9715082-7A BR9715082A (pt) 1996-06-11 1997-06-10 Sistemas transdérmicos contendo dois princìpios ativos em compartimentos separados, seu processo de preparo e sua aplicação como medicamento

Country Status (19)

Country Link
EP (1) EP0904086B1 (pt)
JP (1) JP2000511921A (pt)
CN (1) CN1119150C (pt)
AR (1) AR008229A1 (pt)
AT (1) ATE284215T1 (pt)
AU (1) AU739141B2 (pt)
BR (1) BR9715082A (pt)
CA (1) CA2257913A1 (pt)
CZ (1) CZ295350B6 (pt)
DE (1) DE69731883T2 (pt)
ES (1) ES2235236T3 (pt)
FR (1) FR2749514B1 (pt)
NO (1) NO320999B1 (pt)
PL (1) PL189361B1 (pt)
RU (1) RU2209090C2 (pt)
TR (1) TR199802577T2 (pt)
TW (1) TWI228999B (pt)
WO (1) WO1997047305A1 (pt)
ZA (1) ZA975160B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
US8343538B2 (en) 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
EP2289487A1 (en) 2005-12-27 2011-03-02 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
US10821297B2 (en) * 2016-09-30 2020-11-03 Johnson & Johnson Consumer Inc. Kit and method for topical delivery of benefits
JP6982960B2 (ja) * 2017-02-07 2021-12-17 リンテック株式会社 包材および包装体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel

Also Published As

Publication number Publication date
NO320999B1 (no) 2006-02-27
PL330597A1 (en) 1999-05-24
AU3266197A (en) 1998-01-07
FR2749514B1 (fr) 1998-08-07
CZ295350B6 (cs) 2005-07-13
JP2000511921A (ja) 2000-09-12
EP0904086B1 (fr) 2004-12-08
PL189361B1 (pl) 2005-07-29
ATE284215T1 (de) 2004-12-15
NO985807L (no) 1999-02-10
AR008229A1 (es) 1999-12-29
FR2749514A1 (fr) 1997-12-12
NO985807D0 (no) 1998-12-11
WO1997047305A1 (fr) 1997-12-18
CN1227492A (zh) 1999-09-01
TWI228999B (en) 2005-03-11
DE69731883T2 (de) 2005-12-22
ZA975160B (en) 1998-06-11
AU739141B2 (en) 2001-10-04
ES2235236T3 (es) 2005-07-01
DE69731883D1 (de) 2005-01-13
CZ410898A3 (cs) 1999-09-15
CN1119150C (zh) 2003-08-27
TR199802577T2 (xx) 1999-03-22
CA2257913A1 (fr) 1997-12-18
RU2209090C2 (ru) 2003-07-27
EP0904086A1 (fr) 1999-03-31

Similar Documents

Publication Publication Date Title
PT90764A (pt) Processo para a preparacaode um produto farmaceutico compreendendo um estrogenio e um anti-estrigenio e de composicoes farmaceuticas que os contem
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
DK398587A (da) Antitumorvirksomt laegemiddel
NZ236002A (en) Transdermal delivery system for 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
BR9715082A (pt) Sistemas transdérmicos contendo dois princìpios ativos em compartimentos separados, seu processo de preparo e sua aplicação como medicamento
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
SE8601709L (sv) Farmaceutiskt medel samt komposition innehallande detta
BR0014159A (pt) Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional
KR880009639A (ko) 서방성 매트릭스 제형
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE192338T1 (de) Pharmazeutisches präparat zur synergistischen aktivierung natürlicher killerzellen
GB1098242A (en) Novel benzdiaz[1,4]epine derivatives and a process for the manufacture thereof
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
KR880007079A (ko) 레트로비루스에 감염된 환자치료에 있어서의 3'-디옥시티미딘-2'-엔(3'-디옥시-2',3'-디디하이드로티미딘)의 사용법
KR890001564A (ko) 약학적 투여 단위
KR970032872A (ko) 아세틸살리실산을 함유하는 피부 손상 처치용 약물
ES2060708T3 (es) Sistema terapeutico de liberacion retardada para formulaciones farmaceuticas liquidas.
Finland The new antibiotic era: for better or for worse?
CO4520283A1 (es) Agentes antivirales
BR0107881A (pt) Uso de fsh tratamento de infertilidade
ATE109006T1 (de) Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
IL89335A0 (en) 6-oxo-pyridazine derivatives,a process for their preparation and medicaments containing these compounds
BRPI9912125B8 (pt) benzenossulfoniluréias e - tiouréias 2,5-substituídas, processos para a sua preparação, sua aplicação e preparados farmacêuticos contendo as mesmas
IL94621A0 (en) Pharmaceutical compositions containing vitamin a in association with various therapeutically active ingredients

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: AVENTIS PHARMA S.A. (FR)

Free format text: TRANSFERIDO POR FUSAO DE: HOECHST MARION ROUSSEL

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 9/70, A61K 31/565, A61K 31/575; A61L 15/44; A61P 5/24, A61P 19/10 E A61P 15/18.

Ipc: A61K 9/70, A61K 31/565, A61K 31/575, A61L 15/44, A

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 11A, 12A, 13A, 14A E 15A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 11A, 12A, 13A, 14A E 15A ANUIDADES.